Author information from the last article
Articles by Viktoria Vedeler Amundsen
Correction: Supplementary drug treatment to reduce weight in adolescents with severe obesity
- Johannes Rolin,
- Rønnaug Astri Ødegård,
- Viktoria Vedeler Amundsen,
- Unni Mette Stamnes Köpp,
- Ane Kokkvoll,
- Pétur Benedikt Júlíusson,
- Jøran Hjelmesæth
12.01.2023:
Tidsskr Nor Legeforen 2022; 142: 1250–1. On page 1250 of issue no. 14/2022 of the Journal of the Norwegian Medical Association, the following should be written in the English version of the article: Orlistat (Xenical) is not approved for the treatment of obesity in children aged 12 years or older...
Supplementary drug treatment to reduce weight in adolescents with severe obesity
- Johannes Rolin,
- Rønnaug Astri Ødegård,
- Viktoria Vedeler Amundsen,
- Unni Mette Stamnes Köpp,
- Ane Kokkvoll,
- Pétur Benedikt Júlíusson,
- Jøran Hjelmesæth
05.10.2022:
In 2021, the Norwegian Medicines Agency approved the use of daily injection of liraglutide 3.0 mg (Saxenda) as a supplement to lifestyle treatment for weight control in children ≥ 12 years of age with obesity (isoBMI ≥ 30). We share the treatment experiences of six multidisciplinary obesity clinics...